Citation: | LIAO Suwen, LI Bai, LIAO Bicai. Study on relationships of serum norepinephrine and dopamine levels with severity of children with attention deficit hyperactivity disorder[J]. Journal of Clinical Medicine in Practice, 2022, 26(9): 76-79. DOI: 10.7619/jcmp.20213056 |
[1] |
HATTABI S, BOUALLEGUE M, BEN YAHYA H, et al. Rehabilitation of ADHD children by sport intervention: a Tunisian experience[J]. La Tunisie Med, 2019, 97(7): 874-881.
|
[2] |
LEAHY L G. Diagnosis and treatment of ADHD in children vs adults: what nurses should know[J]. Arch Psychiatr Nurs, 2018, 32(6): 890-895. doi: 10.1016/j.apnu.2018.06.013
|
[3] |
WOLRAICH M L, HAGAN J F, ALLAN C, et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents[J]. Pediatrics, 2019, 144(4): 436-441.
|
[4] |
ANGYAL N, HORVATH E Z, TARNOK Z, et al. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients[J]. Prog Neuro Psychopharmacol Biol Psychiatry, 2018, 84(Pt A): 122-128.
|
[5] |
王淑君, 程芳, 金钱燕. 托莫西汀对多动症儿童心理行为及适应行为的影响观察[J]. 中国妇幼保健, 2020, 35(10): 1838-1840. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB202010026.htm
|
[6] |
Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management, WOLRAICH M, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents[J]. Pediatrics, 2011, 128(5): 1007-1022. doi: 10.1542/peds.2011-2654
|
[7] |
BARRAGÁN E, BREUER D, DÖPFNER M. Efficacy and safety of Omega-3/6 fatty acids, methylphenidate, and a combined treatment in children with ADHD[J]. J Atten Disord, 2017, 21(5): 433-441. doi: 10.1177/1087054713518239
|
[8] |
DANIELSON M L, BITSKO R H, GHANDOUR R M, et al. Prevalence of parent-reported ADHD diagnosis and associated treatment among US children and adolescents, 2016[J]. J Clin Child Adolesc Psychol, 2018, 47(2): 199-212. doi: 10.1080/15374416.2017.1417860
|
[9] |
朱莹, 张超男, 钟祥. 多巴胺受体激动剂治疗小儿多动症的临床疗效及安全性[J]. 中国妇幼保健, 2020, 35(7): 1252-1254. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB202007029.htm
|
[10] |
WANG M, ZHAO Q, KANG H C, et al. Attention deficit hyperactivity disorder (ADHD) in children with epilepsy[J]. Ir J Med Sci, 2020, 189(1): 305-313. doi: 10.1007/s11845-019-02042-3
|
[11] |
NIHAL Y, ENES S. Skin picking successfully treated with atomoxetine in comorbid skin picking and attention-deficit/hyperactivity disorder: a case report[J]. Clin Neuropharmacol, 2020, 43(4): 114-115. doi: 10.1097/WNF.0000000000000393
|
[12] |
MIKLÓS M, FUTÓ J, KOMÁROMY D, et al. Executive function and attention performance in children with ADHD: effects of medication and comparison with typically developing children[J]. Int J Environ Res Public Heal, 2019, 16(20): 3822. doi: 10.3390/ijerph16203822
|
[13] |
熊萍, 林俊, 汪捷峰, 等. 血清多巴胺水平与儿童多动症发生发展的关系及多巴胺受体激动剂的疗效[J]. 广东医学, 2017, 38(20): 3147-3149. https://www.cnki.com.cn/Article/CJFDTOTAL-GAYX201720023.htm
|
[14] |
PINEAU G, VILLEMONTEIX T, SLAMA H, et al. Dopamine transporter genotype modulates brain activity during a working memory task in children with ADHD[J]. Res Dev Disabil, 2019, 92: 103430. doi: 10.1016/j.ridd.2019.103430
|
[15] |
徐凌燕, 滕懿群. 静灵口服液联合中枢神经兴奋剂对160例儿童多动症的临床分析[J]. 中国妇幼健康研究, 2020, 31(10): 1388-1392. https://www.cnki.com.cn/Article/CJFDTOTAL-SANE202010021.htm
|
[16] |
KHADEMVATAN S, RIAHI F, IZADI-MAZIDI M, et al. Toxoplasma gondii exposure and the risk of attention deficit hyperactivity disorder in children and adolescents[J]. Pediatr Infect Dis J, 2018, 37(11): 1097-1100. doi: 10.1097/INF.0000000000001985
|
[17] |
QIAN A D, WANG X, LIU H R, et al. Dopamine D4 receptor gene associated with the frontal-striatal-cerebellar loop in children with ADHD: a resting-state fMRI study[J]. Neurosci Bull, 2018, 34(3): 497-506. doi: 10.1007/s12264-018-0217-7
|
[18] |
NURDAN K, NIHAL Y. Atomoxetine induced skin picking: a case report[J]. Clin Neuropharmacol, 2020, 43(2): 46-47. doi: 10.1097/WNF.0000000000000379
|
[19] |
SEYEDI M, GHOLAMI F, SAMADI M, et al. The effect of vitamin D3 supplementation on serum BDNF, dopamine, and serotonin in children with attention-deficit/hyperactivity disorder[J]. CNS Neurol Disord Drug Targets, 2019, 18(6): 496-501.
|
[20] |
徐小丽, 金丽云. 血清神经递质及微量元素在儿童多动症中的检测价值研究[J]. 中国妇幼保健, 2018, 33(23): 5496-5498. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201823063.htm
|
[21] |
LIAO C, LAPORTE A D, SPIEGELMAN D, et al. Transcriptome-wide association study of attention deficit hyperactivity disorder identifies associated genes and phenotypes[J]. Nat Commun, 2019, 10(1): 4450.
|
[22] |
MARSHALL C A, BRODNIK Z D, MORTENSEN O V, et al. Selective activation of Dopamine D3 receptors and norepinephrine transporter blockade enhances sustained attention[J]. Neuropharmacology, 2019, 148: 178-188.
|
1. |
曲振廷,叶关毅,李环,徐小磊,李素芬. 归脾汤加减治疗儿童学习困难型多动症的临床研究. 吉林医药学院学报. 2024(03): 200-203 .
![]() | |
2. |
张倩,刘广华,何月敏,谢晓颖,徐乐瑶. 整合心理行为干预对多动症患儿认知功能及P300的影响. 中国基层医药. 2024(06): 885-889 .
![]() | |
3. |
苑成浩,杨丽,李明,刘晓亮. 调神益智汤联合生物反馈对学龄期多动症患儿血清ACTH、CORT水平的影响. 四川中医. 2024(07): 129-132 .
![]() | |
4. |
钦云峰,凌寅杰,袁琛. 脑蛋白水解物联合盐酸托莫西汀治疗小儿多动症的效果观察及对患儿认知功能的影响. 中国妇幼保健. 2024(17): 3327-3331 .
![]() | |
5. |
巫慧敏,任妍,朱帝玲,陈月,张素华,秦成洁,罗映娟,杨柳. 四川省成都市42679名学龄前儿童中注意缺陷多动障碍现状调研及影响因素分析. 实用临床医药杂志. 2023(08): 62-66 .
![]() | |
6. |
赵云鹏,白光磊,梁力泳. 自拟清心补气平肝汤联合盐酸托莫西汀治疗注意缺陷多动障碍的临床研究. 国际中医中药杂志. 2023(06): 684-688 .
![]() | |
7. |
张雪宁,谢振中,庞玉兰. 注意缺陷多动障碍患儿肠道细菌构成特点及临床意义. 中国妇幼保健. 2023(14): 2593-2596 .
![]() | |
8. |
李辉. 不同严重程度多动症儿童的血清NE和DA水平及其影响因素分析. 中国处方药. 2023(10): 169-171 .
![]() | |
9. |
徐晓慧. 分析3~10岁儿童注意缺陷多动症状的发生状况及其与睡眠的关系. 世界睡眠医学杂志. 2023(10): 2350-2352 .
![]() |